We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$252M
AUM Growth
-$86.3M
Cap. Flow
-$109M
Cap. Flow %
-43.42%
Top 10 Hldgs %
38.06%
Holding
113
New
35
Increased
12
Reduced
16
Closed
45

Top Buys

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$11M
2
LH icon
Labcorp
LH
+$9.27M
3
MRK icon
Merck
MRK
+$8.29M
4
LIVN icon
LivaNova
LIVN
+$7.92M
5
ATHN
Athenahealth, Inc.
ATHN
+$5.37M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$10.7M
2
BCR
CR Bard Inc.
BCR
+$9.32M
3
GSK icon
GSK
GSK
+$8.25M
4
UNH icon
UnitedHealth
UNH
+$7.79M
5
CNC icon
Centene
CNC
+$7.73M

Sector Composition

Rank Sector Weight
1 Healthcare 65.96%
2 Industrials 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
101
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-60,598
Closed -$2.23M
FLXN
102
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-35,000
Closed -$942K
FPRX
103
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-8,982
Closed -$325K
WMGI
104
DELISTED
Wright Medical Group Inc
WMGI
– –
-175,000
Closed -$4.95M
AIMT
105
DELISTED
Aimmune Therapeutics
AIMT
– –
-70,000
Closed -$1.52M
AGN
106
DELISTED
Allergan plc
AGN
– –
-28,875
Closed -$6.9M
FOMX
107
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-18,900
Closed -$94K
ELGX
108
CALL
DELISTED
Endologix Inc
ELGX
– –
-7,550
Closed -$547K
KTWO
109
DELISTED
K2M Group Holdings, Inc
KTWO
– –
-202,907
Closed -$4.16M
AVXS
110
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-72,625
Closed -$5.52M
CELG
111
DELISTED
Celgene Corp
CELG
– –
-44,000
Closed -$5.47M
SHPG
112
DELISTED
Shire pic
SHPG
– –
-39,125
Closed -$6.82M
BCR
113
DELISTED
CR Bard Inc.
BCR
– –
-37,500
Closed -$9.32M
1 2 3 4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q2 2017 Portfolio in Review

As of Q2 2017, Pura Vida Investments held 113 positions worth $252M, down 26% from $338M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $109M in Q2 2017, closing 45 positions and reducing 16 holdings. Its most notable exit was Hologic, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 74% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Express Scripts Holding Company worth $11.2M.

  • Pura Vida Investments's largest Q2 2017 buy was Express Scripts Holding Company: 174,700 shares worth $11.2M.
  • Pura Vida Investments added most to NanoString Technologies, Inc. in Q2 2017, an estimated $4.51M increase.
  • Pura Vida Investments's biggest Q2 2017 reduction was Exact Sciences, cutting an estimated $6.94M.
  • Pura Vida Investments fully exited Hologic in Q2 2017, selling an estimated $10.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $252M portfolio in Q2 2017.
  • Pura Vida Investments opened 35 new positions and closed 45 in Q2 2017.
  • Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $252M.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.